DALCOR Trademark

Trademark Overview

On Tuesday, April 7, 2015, a trademark application was filed for DALCOR with the United States Patent and Trademark Office. The USPTO has given the DALCOR trademark a serial number of 86589067. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, February 21, 2023. This trademark is owned by Dalcor Pharma UK Ltd. The DALCOR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of therapeutic drugs in the field of biopharmaceuticals
dalcor

General Information

Serial Number86589067
Word MarkDALCOR
Filing DateTuesday, April 7, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, February 21, 2023
Registration Number5020157
Registration DateTuesday, August 16, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 31, 2016

Trademark Statements

Goods and ServicesResearch and development of therapeutic drugs in the field of biopharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 15, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDalcor Pharma UK Ltd
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCheshire WA14 2DT
GB
Party NameDalcor Pharma UK Ltd
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCheshire WA14 2DT
Party NameDalcor Pharma UK Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCheshire WA14 2DT

Trademark Events

Event DateEvent Description
Friday, April 10, 2015NEW APPLICATION ENTERED
Monday, August 3, 2015ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, August 19, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 8, 2015PUBLISHED FOR OPPOSITION
Tuesday, September 8, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 3, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 11, 2016TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, January 11, 201644(e) PETITION - RECEIVED
Wednesday, April 15, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 15, 2015ASSIGNED TO EXAMINER
Wednesday, July 15, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 31, 2015ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, March 1, 2016ASSIGNED TO PETITION STAFF
Monday, March 7, 2016PETITION INQUIRY LETTER ISSUED
Tuesday, March 15, 2016ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Tuesday, April 26, 2016NOTICE OF ALLOWANCE CANCELLED
Sunday, February 7, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 14, 2016TEAS RESPONSE TO PETITION INQUIRY LETTER
Tuesday, March 15, 2016PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Wednesday, May 11, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 16, 2016REGISTERED-PRINCIPAL REGISTER
Monday, August 16, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, August 4, 2022TEAS SECTION 8 & 15 RECEIVED
Tuesday, February 21, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, April 27, 2016CASE RETURNED TO EXAMINATION
Thursday, April 28, 2016POST PUBLICATION AMENDMENT - ENTERED
Tuesday, May 31, 2016PUBLISHED FOR OPPOSITION
Tuesday, May 31, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, August 16, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, February 21, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, February 21, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Related Keywords

dalcor field biopharmaceuticals drugs therapeutic development research